SOBR Safe, Inc. - Common Stock (SOBR)

SOBRsafe (NASDAQ: SOBR), the leader in next-generation alcohol monitoring and detection technology, entered into definitive agreements for the issuance and sale of 1,290,324 shares of common stock (or pre-funded warrants in lieu thereof), along with Series C warrants and Series D warrants to purchase up to an aggregate of 1,290,324 additional shares each , at a combined purchase price of $1.55 per share (or pre-funded warrant in lieu thereof) and associated warrants, in a private placement priced at-the-market under Nasdaq rules. The warrants carry an exercise price of $1.30 per share and are exercisable immediately upon issuance, with the Series C warrants expiring five years and the Series D warrants expiring twenty-four months after the effective date of the applicable resale registration statement. H.C. Wainwright & Co. is acting as exclusive placement agent. The offering is expected to generate approximately $2.0 million in gross proceeds , before fees and expenses, with net proceeds intended for working capital and general corporate purposes.

DENVER, COLORADO / ACCESS Newswire / December 24, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced that it has entered into definitive agreements for the issuance and sale of 1,290,324 shares of its common stock (or pre-funded warrants in lieu thereof), Series C warrants to purchase up to an aggregate of 1,290,324 shares of common stock and Series D warrants to purchase up to an aggregate of 1,290,324 shares of common stock, at a purchase price of $1.55 per share (or pre-funded warrant in lieu thereof) and associated warrants in a private placement priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $1.30 per share and will be exercisable immediately upon issuance. The Series C warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the Series D warrants will expire twenty-four months after the effective date of the Resale Registration Statement.

SOBRsafe (NASDAQ: SOBR), reported Q3 2025 revenue up 136.1 percent year over year, driven by rising adoption of its SOBRsure GEN 2 device, which accounted for more than 80 percent of quarterly revenue and helped push annual recurring software revenue to $152.2 thousand, up 60.5 percent; the Company sold 277 devices, refined its marketing strategy to boost conversions, increased website traffic 266 percent, and achieved its highest monthly sales in October followed by its largest device order in November, while gross profit grew to $37.9 thousand, operating expenses rose with expanded commercial activity, net loss widened to $2.2 million, and cash stood at $4.7 million as SOBRsafe advances commercialization, expands channel partnerships and invests in product development and software capabilities to support long-term growth.

DENVER, COLORADO / ACCESS Newswire / November 12, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, is reporting financial and operating results for the third quarter ended September 30, 2025.

DENVER, CO / ACCESS Newswire / August 25, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, will participate in the 2025 Gateway Conference, which is being held September 3-4, at the Four Seasons Hotel in San Francisco, CA.

SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol monitoring and detection technology, reported a 92.3% year-over-year and 20.3% sequential increase in Q2 2025 revenue to $104,200, driven primarily by SOBRsure(TM) GEN 2 hardware and software sales, which comprised 76.5% of total revenue. Gross margin rose 380 basis points to 57.5%, while net loss narrowed to $2.0 million from $2.1 million in Q2 2024. The company shipped 178 SOBRsure(TM) GEN 2 devices, up 35.9% from Q1, and grew annual recurring software subscription revenue 109.6% year-over-year to 55.2% of quarterly revenue. Operational highlights included independent third-party validation of SOBRsure(TM) GEN 2 performance, launch of an upgraded B2B e-commerce platform, issuance of a European Patent for SOBRcheck(TM), sales team expansion, and entry into the Family Law market. Cash and equivalents stood at $8.5 million as of June 30, 2025.

DENVER, CO / ACCESS Newswire / August 7, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, is reporting financial and operating results for the second quarter ended June 30, 2025.

SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol monitoring technology, announced the European Patent Office has granted European Patent No. EP4171362 for its SOBRcheck(TM) device. The patent covers the Company’s proprietary noninvasive transdermal alcohol screening system, which uses skin-contact verification, biometric ID scanning, and wireless data transmission to detect alcohol consumption without intrusive sampling. The intellectual property strengthens SOBRsafe’s position in workplace safety, judicial compliance, and wellness markets ahead of planned European pilot programs in the second half of 2025.

Gateway Conference expected to draw 300+ institutional investors for company presentations and exclusive one-on-one meetings

European Patent Office Grants Patent for the Company's SOBRcheck™ Device

Independent Testing Confirms SOBRsure™ GEN 2 Capabilities, Positioning SOBRsafe for Accelerated Market Expansion

SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol detection technology, reported strong results for the first quarter ended March 31, 2025, with revenue increasing 80.5% year-over-year to $86.6K and gross margin improving to 58.8%. Net loss narrowed to $1.9 million from $2.5 million a year ago, driven by increased software subscriptions and SOBRsure(TM) device sales. Software subscription revenue, now 53.8% of total revenue, more than doubled. The company deployed 148 SOBRsure(TM) devices, a 41% increase from year-end, and strengthened its leadership with key board and advisory additions. SOBRsafe ended the quarter with $10.1 million in cash following $3.3 million in warrant exercises tied to its October 2024 PIPE financing.

DENVER, CO / ACCESS Newswire / May 22, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, is reporting financial and operating results for the first quarter ended March 31, 2025.

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM (NYSE: IBM), and PwC, to its Board of Directors effective May 1, 2025, where she will also chair the Nominating and Corporate Governance Committee. The Company also named Dr. Benjamin Sanchez as a Scientific Advisor in February to support federal funding and clinical research partnerships. The additions bring deep expertise in governance, digital innovation, and biomedical engineering as SOBRsafe continues scaling its alcohol detection technology platform.

Appointed Dr. Benjamin Sanchez as a Scientific Advisor

SOBRsafe (NASDAQ: SOBR), the leader in next-generation alcohol monitoring and detection technology, issued a corporate update highlighting key achievements in 2024 and outlining strategic initiatives for 2025. The Company reported a 35% increase in revenue to $212.7 thousand for 2024, with a 20% reduction in operating expenses and a 16% improvement in net loss. Notable initiatives include multi-channel marketing campaigns, expansion into 43 U.S. states and international markets, and new deployments of the SOBRsure wearable device. SOBRsafe also appointed a new vice president of sales, introduced product enhancements, and began alcohol detection programs for airport personnel abroad. Operationally, the Company completed product validation studies and AI-supported testing, while financially maintaining $8.4 million in cash and no long-term debt. A 1-for-10 reverse stock split was completed in April 2025 to streamline share structure.

SOBRsafe is Positioned for a Strong 2025 as the Company Continues to Make Progress on Third Party Validation; Driving Sales Growth Through Enhanced Marketing Efforts; Ramping Personnel Support; and Remains Well Capitalized with No Debt

SOBRsafe (NASDAQ: SOBR) has released key findings from a survey of 1,001 American women aged 40 to 65 who consume alcohol, revealing how midlife challenges drive increased alcohol use. The study, released during Alcohol Awareness Month and following a U.S. Surgeon General warning about alcohol’s link to cancer, found that many women drink to manage anxiety, parenting stress, and loneliness. Nearly half expressed concern over their drinking habits, but barriers like shame, social pressure, and cost prevent many from seeking help. SOBRsafe aims to promote awareness and support with tools like its SOBRsure band to help women pursue healthier lifestyles.

SOBRsafe (NASDAQ: SOBR) provider of next-generation transdermal alcohol detection solutions, will implement a 1-for-10 reverse stock split effective at 12:01 a.m. ET on April 4, 2025, following board approval and prior shareholder authorization. Post-split trading will begin the same day under the existing ticker with a new CUSIP number. The split will reduce outstanding shares from roughly 15.2 million to approximately 1.5 million, with all shareholders maintaining their proportional ownership. Fractional shares will be rounded up, and all related securities such as warrants and equity awards will be proportionally adjusted. Equiniti Trust Company, LLC will manage the exchange process.

DENVER, CO / ACCESS Newswire / April 2, 2025 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today announced that it will proceed with a 1-for-10 reverse stock split ("Reverse Stock Split") of its outstanding shares of common stock (the "Common Stock") following approval by its board of directors. This ratio is within the range approved by stockholders at the annual meeting of SOBRsafe's shareholders held on December 9, 2024.

SOBRsafe (NASDAQ: SOBR) announced a strategic partnership with Orbiit, an AI-driven alcohol recovery platform, to integrate wearable alcohol detection technology with real-time behavioral support. The collaboration pairs SOBRsafe’s transdermal SOBRsure wristband with Orbiit’s AI-powered engagement platform, offering continuous monitoring, 24/7 AI support, and SMS-based accountability messaging. This initiative aims to enhance recovery outcomes by providing accessible, data-driven tools for individuals managing sobriety. The six-month Orbiit Recovery Program, priced at $3,995, includes the SOBRsure band and full platform access, marking a significant step in modernizing alcohol recovery support.

As technology and industry trends accelerate, several innovative companies are driving transformation across key sectors such as AI, defense, 5G, and energy metals. From next-generation connectivity to breakthrough military and healthcare solutions, these companies are capturing investor attention with their disruptive potential and strong market momentum.

Peraso Inc. (NASDAQ: PRSO) has established itself as a global leader in 60 GHz millimeter wave (mmWave) semiconductor technology, distinguishing itself as the only publicly traded pure-play mmWave semiconductor company . Specializing in fully integrated solutions across the mmWave signal chain, Peraso provides cutting-edge performance, reliability, and cost efficiency . Its comprehensive product suite positions the company as a one-stop shop for next-generation wireless connectivity , catering to the increasing demand for high-speed, low-latency communication in applications such as drones, 5G infrastructure, and high-bandwidth networking .

SOBRsafe (NASDAQ: SOBR) has introduced SOBRsure, a wristband that detects alcohol through transdermal technology, offering real-time monitoring for individuals, families, and businesses. CEO David Gandini emphasized its role as both an accountability tool and a vital resource for those managing sobriety. The global drug screening market is poised for rapid growth, driven by rising substance abuse and stricter regulations. According to the World Drug Report 2023, drug use increased by 23% over a decade, while alcohol-related traffic fatalities in the U.S. rose 14% in a single year. Market forecasts project the industry to reach $19.5 billion by 2029, with North America leading the expansion. As demand for innovative screening solutions rises, SOBR Safe’s technology positions the company at the forefront of the alcohol detection market.

EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END